Metraipolis › archive › dc_08d18e265654

Repurposing the HMG-CoA reductase inhibitor atorvastatin for SRD5A3-congenital disorder of glycosylation — Europe PMC PMID:42839006

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42839006
DOI
10.1038/s43856-[numero omesso]-4
License (as archived)
solo-consultazione
Archived
2026-10-17T08:57:00.858Z
SHA-256 of the archived text
0180d39fd6845cc28add6dd28fb8708162f6f11f7221f5ff14776bcfa6b1ea2c
Stable URL of this page
https://metraipolis.com/documento/dc_08d18e265654

How to cite

Repurposing the HMG-CoA reductase inhibitor atorvastatin for SRD5A3-congenital disorder of glycosylation — Europe PMC PMID:42839006 — Europe PMC (en), https://europepmc.org/article/MED/42839006 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_08d18e265654 (Metraipolis archive dc_08d18e265654, sha256 0180d39fd6845cc28add6dd28fb8708162f6f11f7221f5ff14776bcfa6b1ea2c)
BibTeX
@misc{dc08d18e265654,
  title = {Repurposing the HMG-CoA reductase inhibitor atorvastatin for SRD5A3-congenital disorder of glycosylation — Europe PMC PMID:42839006},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42839006},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_08d18e265654; sha256 0180d39fd6845cc28add6dd28fb8708162f6f11f7221f5ff14776bcfa6b1ea2c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42839006. Agents can read the archived copy with the MCP tool read_document.